Figure 1. Effect of Idarucizumab on the Anticoagulation Effect of Dabigatran
DE, dabigatran etexilate; dTT, diluted thrombin time; RI, renal impairment (CLcr: mild RI ≥ 60 to < 90 mL/min; moderate RI ≥ 30 to < 60 mL/min); TT, thrombin time.
Reproduced with permission from J Stangier, PhD.